By Aaron E. Carroll The endless array of diets that claim to help you shed pounds tend to fall into two camps: low fat or low carbohydrate. Some companies even claim that genetics can tell us which diet is better for which people. A rigorous recent study sought to settle the debate, and it had results to disappoint both camps. On the hopeful side, as The New York Times noted, people managed to lose weight no matter which of the two diets they followed. The study is worth a closer look to see what it did and did not prove. Researchers at Stanford University took more than 600 people (which is huge for a nutrition study) aged 18 to 50 who had a body mass index of 28 to 40 (25-30 is overweight, and 30 and over is obese). The study subjects had to be otherwise healthy. They couldn’t even be on statins, or drugs for Type 2 diabetes or hypertension, which might affect weight or energy expenditure. They were all randomly assigned to a healthful low-fat or a healthful low-carbohydrate diet, and they were clearly not blinded to which group they were in. All participants attended 22 instructional sessions over one year in groups of about 17 people. The sessions were held weekly at first and were then spaced out so that they were monthly in the last six months. Everyone was encouraged to reduce intake of the avoided nutrient to 20 grams per day over the first eight weeks, then participants slowly added fats or carbohydrates back to their diets until they reached the lowest level of intake they believed could be sustained for the long haul. Everyone was followed for a year (which is an eternity for a nutrition study). Everyone was encouraged to maximize vegetable intake; to minimize added sugar, refined flour and trans fat intake; and to focus on whole foods that were minimally processed. The subjects were also encouraged to cook at home as much as possible. © 2018 The New York Times Company

Keyword: Obesity
Link ID: 24783 - Posted: 03.26.2018

By Amina Zafar, Susan Caluori says a stroke saved her life. The 60-year-old Montreal woman had just run a half marathon in December 2015 when her husband noticed the left side of her face was drooping. She wanted to keep watching TV, but he insisted they go to the hospital. The doctors there treated her for a stroke, the facial droop, and she was discharged a week later. A couple of weeks passed, and she returned to the emergency department after becoming confused and disoriented and experiencing speech difficulties. It was then that doctors performed a series of tests that led them to identify a blood clot in one of her heart valves. With the help of a biopsy, they found the cause of the clot was a dangerous form of ovarian cancer. "The empress of subterfuge," her doctors called the cancer masquerading as a stroke. It turns out that it was the malignancy in her Fallopian tubes that was the source behind her drooping face and the mixed-up words that her kids had been teasing her about for two months prior to her emergency room visit. "The stroke saved my life. Yes, I have repercussions because of the strokes, but you know what, I'm alive because of them. If not [for them], they would have never have found the cancer," Caluori said. Caluori's presentation was so rare that her medical team wrote up the case report in a medical journal last year. "What alerted us to her having ovarian cancer is nothing in her abdomen or pelvis," said Dr. Ziggy Zeng, a gynecological oncologist at the McGill University Health Centre. "The disease is so cunning it presented itself with a clot." The ovarian cancer caused Caluori's blood to produce a clot that triggered the strokes, Zeng said. ©2018 CBC/Radio-Canada.

Keyword: Stroke
Link ID: 24782 - Posted: 03.26.2018

By Nora D. Volkow As a young scientist in the 1980s, I used then-new imaging technologies to look at the brains of people with drug addictions and, for comparison, people without drug problems. As we began to track and document these unique pictures of the brain, my colleagues and I realized that these images provided the first evidence in humans that there were changes in the brains of addicted individuals that could explain the compulsive nature of their drug taking. The changes were so stark that in some cases it was even possible to identify which people suffered from addiction just from looking at their brain images. Alan Leshner, who was the Director of the National Institute on Drug Abuse at the time, immediately understood the implications of those findings, and it helped solidify the concept of addiction as a brain disease. Over the past three decades, a scientific consensus has emerged that addiction is a chronic but treatable medical condition involving changes to circuits involved in reward, stress, and self-control; this has helped researchers identify neurobiological abnormalities that can be targeted with therapeutic intervention. It is also leading to the creation of improved ways of delivering addiction treatments in the healthcare system, and it has reduced stigma. Informed Americans no longer view addiction as a moral failing, and more and more policymakers are recognizing that punishment is an ineffective and inappropriate tool for addressing a person’s drug problems. Treatment is what is needed. © 2018 Scientific American, a Division of Nature America, Inc.

Keyword: Drug Abuse
Link ID: 24781 - Posted: 03.26.2018

Juliette Jowit The world’s first brain scanner that can be worn as people move around has been invented, by a team who hope the contraption can help children with neurological and mental disorders and reveal how the brain handles social situations. The new scalp caps – made on 3D printers – fit closely to the head, so can record the electromagnetic field produced by electrical currents between brain cells in much finer detail than previously. This design means the scanner can work in ways never possible before: subjects can move about, for example, and even play games with the equipment on, while medics can use it on groups such as babies, children and those with illnesses which cause them to move involuntarily. “This has the potential to revolutionise the brain imaging field, and transform the scientific and clinical questions that can be addressed with human brain imaging,” said Prof Gareth Barnes at University College London, one of three partners in the project. The other two are the University of Nottingham and the Wellcome Trust. The brain imaging technique known as magnetoencephalography, or MEG, has been helping scientists for decades, but in many cases has involved using huge contraptions that look like vintage hair salon driers. The scanners operated further from the head than the new devices, reducing the detail they recorded, and users had to remain incredibly still. © 2018 Guardian News and Media Limited

Keyword: Brain imaging
Link ID: 24780 - Posted: 03.22.2018

/ By Charles Schmidt In August of 2013, Shecara Norris moved with her husband and five young children into a rented colonial house in East Columbus, Ohio. She was in her late 20s and pregnant with her sixth child. The house was in a crime-ridden area that Norris describes as the “heart of the hood,” but it also had a lot of appeal, with wood floors, a dining room with a fireplace, and plenty of room for her growing family. Her son Michael — who had been born earlier that year — was a healthy baby with a strong personality. Shecara Norris with her son Michael, whose blood lead levels were once six times higher than a standard federal benchmark. Lowering that benchmark further, critics say, will make it harder for children like Michael to get the resources they need. Current policy “trivializes the continuing problem of clinical childhood lead poisoning in the interiors of our major cities,” one epidemiologist argued. But around the time of his second birthday, doctors found lead in Michael’s blood. At 30 micrograms per deciliter (mcg/dL), his blood lead levels were six times over the amount that triggers case management recommendations by the federal Centers for Disease Control and Prevention. State and local public health officials were notified, and Norris and her husband were told it wasn’t safe for Michael to remain in the house, though the family didn’t have the money to leave. To Norris, the diagnosis initially came as a shock, though it seems less surprising in hindsight. The house dates back nearly a century, to a time when lead paint was used routinely. Inspectors would later find that nearly every room was contaminated with the toxic metal, as were the front porch and the yard where Michael and his brothers and sisters would play. Lead is much more dangerous to young children than adults, targeting developing nervous systems and progressively lowering intelligence with increasing doses. All the Norris children had lead in their blood, but Michael’s levels were by far the highest. Copyright 2018 Undark

Keyword: Development of the Brain; Neurotoxins
Link ID: 24779 - Posted: 03.22.2018

By David Grimm After years of experiments, a protracted battle to grant them legal “personhood,” and a life spent bouncing between two scientific facilities, two of the world’s most famous research chimpanzees have finally retired. Hercules and Leo arrived this morning at Project Chimps, a 95-hectare sanctuary in the wooded hills of Morgantown, Georgia. In many ways, the pair had also become the face of a tortuously slow effort to move hundreds of the United States’s remaining research chimpanzees to wildlife refuges. Their arrival at Project Chimps suggests plans to retire these animals—which can live up to 50 years in captivity—may be back on track. “For the first time, there are more chimpanzees in sanctuaries than there are in labs,” says Stephen Ross, director of the Lester E. Fisher Center for the Study and Conservation of Apes at the Lincoln Park Zoo in Chicago, Illinois, and board chair of Chimp Haven in Keithville, Louisiana, the only sanctuary authorized to take government-owned chimps. “Hercules and Leo are representative of a movement that’s finally bearing fruit.” Hercules and Leo were born in 2006 at the New Iberia Research Center in Louisiana, home to the world’s largest collection of privately owned lab chimps. In 2011, New Iberia loaned the duo out to the State University of New York in Stony Brook. There, they lived in a three-room enclosure and researchers inserted small electrodes into their muscles to study the evolution of bipedal walking. While there, the Nonhuman Rights Project—an animal rights group based in Coral Springs, Florida—filed a lawsuit to have Hercules and Leo declared legal persons and moved to a sanctuary in Florida. Despite multiple appeals over 2 years, the effort failed, and the chimps were shipped back to New Iberia in 2015. © 2018 American Association for the Advancement of Scienc

Keyword: Animal Rights
Link ID: 24778 - Posted: 03.22.2018

Aimee Cunningham As mice plumped up on a high-fat diet, some of their taste buds vanished. This disappearing act could explain why some people with obesity seem to have a weakened sense of taste, which may compel them to eat more. Compared with siblings that were fed normal mouse chow, mice given high-fat meals lost about 25 percent of their taste buds over eight weeks. Buds went missing because mature taste bud cells died off more quickly, and fewer new cells developed to take their place. Chronic, low-level inflammation associated with obesity appears to be behind the loss, researchers report March 20 in PLOS Biology. Taste buds, each a collection of 50 to 100 cells, sense whether a food is sweet, sour, bitter, salty or umami (savory). These cells help identify safe and nourishing food, and stimulate reward centers in the brain. The tongue’s taste bud population is renewed regularly; each bud lasts about 10 days. Special cells called progenitor cells give rise to new taste bud cells that replace old ones. Some studies have suggested that taste becomes duller in people with obesity, although why that is has remained unclear. But if taste becomes less intense, “then maybe you don’t get the positive feeling that you should,” which could give way to more overeating, says study coauthor Robin Dando, who studies the biology of taste at Cornell University. Nearly 40 percent of U.S. adults have obesity, determined by a person’s body mass index, a ratio of weight to height. The condition is linked to a number of health problems, including heart disease, diabetes and cancer. |© Society for Science & the Public 2000 - 2018

Keyword: Obesity; Chemical Senses (Smell & Taste)
Link ID: 24777 - Posted: 03.21.2018

By Shawna Williams | Humans like to fancy ourselves advanced, but there’s at least one area where cockroaches, and even nematodes, seem to have us beat: magnetoreception, the ability to sense variations in magnetic fields. To add insult to injury, our best human minds haven’t yet been able to answer basic questions about how the sense—also shared by some amphibians, fish, birds, and mammals—works. Joining the list now are zebrafish and medaka, as researchers reported in Nature Communications last month (February 23). Unlike in some animals, magnetoreception in the fish doesn’t require light to work. The study is “a promising beginning,” writes Roswitha Wiltschko, a researcher at Goethe University Frankfurt who has studied magnetoreception in birds, in an email to The Scientist. “[T]o demonstrate [sensitivity to magnetic direction] in two species whose genetics are known is novel, and this might form a basis for future investigations.” Animals as diverse as lobsters and pigeons are thought to use variations in Earth’s magnetic fields to orient themselves. One idea for how the sense might work is that magnetic fields could affect light-sensitive chemical reactions, possibly in structures in the retina known as cryptochromes. Another is that some animal cells contain magnetic field–sensitive metals that interact with mechanosensitive structures to produce a signal. © 1986-2018 The Scientist

Keyword: Pain & Touch
Link ID: 24776 - Posted: 03.21.2018

By Simon Makin Everyone has unwelcome thoughts from time to time. But such intrusions can signal serious psychiatric conditions—from “flashbacks” in post-traumatic stress disorder (PTSD) to obsessive negative thinking in depression to hallucinations in schizophrenia. “These are some of the most debilitating symptoms,” says neuroscientist Michael Anderson of the University of Cambridge. New research led by Anderson and neuroscientist Taylor Schmitz, now at McGill University, suggests these symptoms may all stem from a faulty brain mechanism responsible for blocking thoughts. Researchers studying this faculty usually focus on the prefrontal cortex (PFC), a control center that directs the activity of other brain regions. But Anderson and his colleagues noticed that conditions featuring intrusive thoughts—such as schizophrenia—often involve increased activity in the hippocampus, an important memory region. The severity of symptoms such as hallucinations also increases with this elevated activity. In the new study, Anderson and his team had healthy participants learn a series of word pairs. The subjects were presented with one word and had to either recall or suppress the associated one. When participants suppressed thoughts, brain scans detected increased activity in part of the PFC and reduced activity in the hippocampus. The findings, which were published last November in Nature Communications, are consistent with a brain circuit in which a “stop” command from the PFC suppresses hippocampus activity. © 2018 Scientific American

Keyword: Attention; Learning & Memory
Link ID: 24775 - Posted: 03.21.2018

By KAREN BARROW Narcolepsy is a sleep disorder that causes excessive sleepiness and frequent daytime sleep attacks. What is it like to never feel fully rested? Three women discuss the realities of living with a sleep disorder. Kailey Profeta learned she had narcolepsy at age 9 after her mother noticed she was unusually tired and had inexplicably gained a lot of weight. Kailey was home-schooled for several years while she and her family learned what combinations of medicines and behavioral adjustments worked to keep her on a normal sleep schedule. She now takes a medicine every night that helps her sleep, but leaves her nauseated in the morning. To cope, she eats breakfast in bed and takes other medications to help her stay awake during the day. Kailey goes home from school every day during third period to take a nap, and she rests again after school. Kailey, who wants to be a fashion designer, works at a bridal boutique during the summer and on weekends. She said that most of her friends understand when she has to rest, but that being a teenager with narcolepsy is not always easy. Patricia A. Higgins suffers from narcolepsy with cataplexy – sudden muscle weakness that causes her to fall and feel temporarily paralyzed. She first began falling from cataplexy as a teenager, and the condition reached its worst point when she was 32; she remembers falling 17 times in one weekend. Getting the correct diagnosis was a struggle. Ms. Higgins went from doctor to doctor and was told at various times that she had a seizure disorder and a psychiatric condition. Eventually, a sleep study confirmed that she had narcolepsy. Narcolepsy has disrupted Ms. Higgins’s work and family life. She is married and the mother of three children, but she left her job as a nurse and cannot drive. She volunteers regularly with the Narcolepsy Network, a support and information group for narcoleptics. © 2018 The New York Times Company

Keyword: Narcolepsy
Link ID: 24774 - Posted: 03.21.2018

By Jim Daley Mice exposed to bisphenol A (BPA) during pregnancy give birth to offspring with atypical brain development and abnormal behavior later in life, according to a study presented yesterday (March 19) at the annual meeting of the Endocrine Society in Chicago. Previous studies have linked BPA, which is found in a wide array of consumer products including plastic water bottles, to numerous diseases. In 2015, Deborah Kurrasch, a neuroscientist at the University of Calgary, and her colleagues found that the chemical can also alter brain development and cause hyperactivity at low doses in zebrafish. Kurrasch and her colleagues then decided to investigate whether similar alterations occurred in mammals, Dinu Nesan, a postdoctoral fellow in Kurrasch’s lab, said during a presentation. After feeding pregnant mice meals containing varying doses of BPA, the researchers observed that even when animals were exposed to low levels of the chemical—10 or 20 times below the recommended daily intake for humans—their offspring displayed significantly accelerated early neuron development. BPA exposure increased the number, size, and the rate of proliferation of neurons in the pups’ brains, but also reduced the “stemness,” or self-renewal capability, of cells, pushing them toward a more differentiated state. According to Nesan, the team also discovered that these effects could be “fully abrogated” with a combination of endocrine receptor and androgen receptor antagonists. © 1986-2018 The Scientist

Keyword: Development of the Brain; Neurotoxins
Link ID: 24773 - Posted: 03.21.2018

By James Gallagher Doctors have taken a major step towards curing the most common form of blindness in the UK - age-related macular degeneration. Douglas Waters, 86, could not see out of his right eye, but "I can now read the newspaper" with it, he says. He was one of two patients given pioneering stem cell therapy at Moorfields Eye Hospital in London. Cells from a human embryo were grown into a patch that was delicately inserted into the back of the eye. Douglas, who is from London, developed severe age-related macular degeneration in his right eye three years ago. The macula is the part of the eye that allows you to see straight ahead - whether to recognise faces, watch TV or read a book. He says: "In the months before the operation my sight was really poor and I couldn't see anything out of my right eye. "It's brilliant what the team have done and I feel so lucky to have been given my sight back." The macula is made up of rods and cones that sense light and behind those are a layer of nourishing cells called the retinal pigment epithelium. When this support layer fails, it causes macular degeneration and blindness. Doctors have devised a way of building a new retinal pigment epithelium and surgically implanting it into the eye. The technique, published in Nature Biotechnology, starts with embryonic stem cells. These are a special type of cell that can become any other in the human body. © 2018 BBC.

Keyword: Vision; Stem Cells
Link ID: 24772 - Posted: 03.20.2018

Michelle Andrews Federal officials have recommended a vaccine against shingles that is more effective than an earlier version at protecting older adults from the painful rash. But persuading many adults to get this and other recommended shots continues to be an uphill battle, health providers say. " 'I'm healthy; I'll get that when I'm older,' " is what adult patients often tell Dr. Michael Munger when he brings up an annual flu shot or a tetanus-diphtheria booster or the new shingles vaccine. Sometimes, he says, they put him off by questioning a vaccine's effectiveness. Munger, a family physician in Overland Park, Kan., who is president of the American Academy of Family Physicians, says he gets more pushback from adults about getting their own vaccines than about immunizing their children. "As parents, we want to make sure our kids are protected. But as adults, we act as if we're invincible." The new schedule for adult vaccines for people age 19 and older has been updated in the last several months by the federal Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices. The most significant change was to recommend Shingrix, the shingles vaccine that was approved by the Food and Drug Administration last fall, over an older version of the vaccine. Shingrix should be given in two doses between two and six months apart to adults who are at least 50 years old, the CDC says. The older vaccine, Zostavax, can still be given to adults who are 60 or older, but Shingrix is preferred, according to the agency. © 2018 npr

Keyword: Pain & Touch
Link ID: 24771 - Posted: 03.20.2018

Ian Sample Science editor Apart from the wide-eyed bike ride home from the lab, his neighbour turning into a witch, the threatening behaviour of his furniture and the futile battle to save his ego from collapse, Dr Albert Hofmann appeared to enjoy his first trip on LSD. Now, 75 years after the Swiss chemist witnessed the full effects of his psychedelic invention, scientists have discovered fresh details of how the drug affects the brain. Scans of healthy volunteers show that less than half the dose that left Hofmann cowering on his sofa makes a person’s sense of self disintegrate. Researchers at the University of Zurich gave willing participants 100 micrograms of LSD – compared with the 250 micrograms Hofmann took on what is now known as “bicycle day” in 1943 – and found that in social interactions with computer avatars, the drug dampened down brain activity that helps people distinguish themselves from others. “Our interpretation is that LSD reduces your sense of integrated self,” said Katrin Preller, a psychologist who worked on the study. “In this particular case, the drug blurs the boundary between what is you and what is another person.” The dissolution of the ego, or self, that destroys the normally concrete sense of where one person ends and another begins, underpins the experience that some LSD users report of feeling at one with the cosmos. Preller and her colleagues studied LSD, or lysergic acid diethylamide, or plain “acid”, to learn how the brain creates a sense of self. By shedding light on the mystery, they hope to find new treatments for symptoms of psychiatric disorders such as depression and schizophrenia, where the sense of self can become heavily distorted. © 2018 Guardian News and Media Limited

Keyword: Drug Abuse
Link ID: 24770 - Posted: 03.20.2018

By Kas Roussy, Robert Van Herpt was 53 when he decided to overhaul his life. A heavy drinker and smoker, he quit both at once cold turkey. He started a new antidepressant. It was, in many ways, a new beginning. But it didn't go according to plan. Before long, Van Herpt stopped sleeping. And that's when he started seeing things. The fruit flies came first. "I'd be sitting and here's a swarm," he said. "I honestly put my arm out and said I could feel them up against my arm. It was that true." Then in the nighttime, from his upstairs bedroom window, in Kingston, Ont., he thought he could see someone damaging his wife's car. He also thought people were partying downstairs in his home. "He was definitely seeing things that weren't there," said his wife, Joanne. "The hallucinations were very drastic in the evening. Really vivid hallucinations." To emphasize the point, Robert repeated: "Really vivid." The couple left home for Kingston General Hospital's emergency department, where the hallucinations continued. At one point, while Joanne was talking to one of the attending doctors, Robert thought he saw another doctor spitting on him. Eventually, the Van Herpts learned that Robert was in the throes of delirium tremens, a condition that can be caused by abruptly stopping a long period of drinking. "Basically when you quit cold turkey, the brain goes through a chemical reaction," Joanne was told. ©2018 CBC/Radio-Canada.

Keyword: Drug Abuse
Link ID: 24769 - Posted: 03.20.2018

Amy Fleming Charles Ryan has a clinic in San Francisco at which he regularly relieves men of their testosterone. This “chemical castration”, as it is sometimes known, is not a punishment, but a common treatment for prostate cancer. Testosterone doesn’t cause the disease (currently the third most deadly cancer in the UK), but it fuels it, so oncologists use drugs to reduce the amount produced by the testicles. Ryan gets to know his patients well over the years, listening to their concerns and observing changes in them as their testosterone levels fall. Because it involves the so-called “male hormone”, the therapy poses existential challenges to many of those he treats. They know that every day, millions of people – from bodybuilders and cheating athletes to menopausal women – enhance their natural levels of testosterone with the aim of boosting their libido, muscle mass, confidence and energy. So what happens when production is suppressed? Might they lose their sex drive? Their strength? Their will to win? The fears are not always groundless. Side-effects can also include fatigue and weight gain. But Ryan has witnessed positives, too. As professor of medicine and urology at the University of California, he has noticed that the medical students who have passed through his clinic in the 18 years that he has been treating prostate cancer invariably comment: “Dr Ryan, your patients are so nice.” He replies, jokingly: “It’s because they don’t have any testosterone. They can’t be mean.” © 2018 Guardian News and Media Limited

Keyword: Aggression; Hormones & Behavior
Link ID: 24768 - Posted: 03.20.2018

Fergus Walsh Doctors say a stem cell transplant could be a "game changer" for many patients with multiple sclerosis. Results from an international trial show that it was able to stop the disease and improve symptoms. It involves wiping out a patient's immune system using cancer drugs and then rebooting it with a stem cell transplant. Louise Willetts, 36, from Rotherham, is now symptom-free and told me: "It feels like a miracle." A total of 100,000 people in the UK have MS, which attacks nerves in the brain and spinal cord. Just over 100 patients took part in the trial, in hospitals in Chicago, Sheffield, Uppsala in Sweden and Sao Paolo in Brazil. They all had relapsing remitting MS - where attacks or relapses are followed by periods of remission. The interim results were released at the annual meeting of the European Society for Bone and Marrow Transplantation in Lisbon. The patients received either haematopoietic stem cell transplantation (HSCT) or drug treatment. After one year, only one relapse occurred among the stem cell group compared with 39 in the drug group. After an average follow-up of three years, the transplants had failed in three out of 52 patients (6%), compared with 30 of 50 (60%) in the control group. Those in the transplant group experienced a reduction in disability, whereas symptoms worsened in the drug group. Prof Richard Burt, lead investigator, Northwestern University Chicago, told me: "The data is stunningly in favour of transplant against the best available drugs - the neurological community has been sceptical about this treatment, but these results will change that. Prof John Snowden, director of blood and bone marrow transplantation at Sheffield's Royal Hallamshire Hospital, told me: "We are thrilled with the results - they are a game changer for patients with drug resistant and disabling multiple sclerosis". © 2018 BBC

Keyword: Multiple Sclerosis; Neuroimmunology
Link ID: 24767 - Posted: 03.19.2018

By LEONARD MLODINOW Ten years ago, when my son Nicolai was 11, his doctor wanted to put him on medication for attention deficit hyperactivity disorder. “It would make him less wild,” I explained to my mother, who was then 85. “It would slow him down a bit.” My mother grumbled. “Look around you,” she said in Yiddish. “Look how fast the world is changing. He doesn’t need to slow down. You need to speed up.” It was a surprising recommendation from someone who had never learned to use a microwave. But recent research suggests she had a point: Some people with A.D.H.D. may be naturally suited to our turbocharged world. Today the word “hyperactive” doesn’t just describe certain individuals; it also is a quality of our society. We are bombarded each day by four times the number of words we encountered daily when my mother was raising me. Even vacations are complicated — people today use, on average, 26 websites to plan one. Attitudes and habits are changing so fast that you can identify “generational” differences in people just a few years apart: Simply by analyzing daily cellphone communication patterns, researchers have been able to guess the age of someone under 60 to within about five years either way with 80 percent accuracy. To thrive in this frenetic world, certain cognitive tendencies are useful: to embrace novelty, to absorb a wide variety of information, to generate new ideas. The possibility that such characteristics might be associated with A.D.H.D. was first examined in the 1990s. The educational psychologist Bonnie Cramond, for example, tested a group of children in Louisiana who had been determined to have A.D.H.D. and found that an astonishingly high number — 32 percent — did well enough to qualify for an elite creative scholars program in the Louisiana schools. © 2018 The New York Times Company

Keyword: ADHD
Link ID: 24766 - Posted: 03.19.2018

By Daniel S. Barron It was midday when an ambulance brought Rose to the Emergency Department. The triage nurses, with their characteristic knack for brevity, had written “50 year old schizophrenic woman hearing/seeing dead boyfriend.” The medical team had done the standard workup—temperature, blood pressure, EKG, labs to screen for an electrolyte imbalance, drug or toxin that might explain Rose’s condition. Everything seemed normal, making Rose (whose name and narrative details have been changed to protect her privacy) a psychiatry patient. So I made my way to the B wing of the E.D., which serves as a Limbo of sorts between the medical and psychiatric services. The B wing invariably bustles with activity. A long concierge-style counter with three computers faces the center of the room, which is essentially a large rectangle. When seated at one of these computers, you can see into each of the nine patient rooms that wrap around the three outer walls. From this vantage, the B wing becomes an amphitheater, with patients in gurney-sized niches showcasing some emergent medical concern: B7, chest pain; B9, acute shortness of breath. Rose was medically cleared, so her gurney had been downgraded to stage right, to the end of the counter. I entered at stage left and noticed her across the room, feet at the head of the gurney propped on a pillow; her head was at the foot, neck slightly bent over the edge. Her hands were neatly resting on her belly while her thick hair formed a graying river that reached towards the linoleum. In a firm yet conversational tone, Rose said towards the ceiling, “Why would Steven say he isn’t dead? How could anyone be so cruel?” Her mouth moved widely like a Claymation character as she slowly enunciated every syllable, chopping cruel into CRU-EL. She was smiling. I stood quietly, observing the scene as Rose stared intensely upwards. A few seconds later, it occurred to me that she was waiting for the ceiling to reply. “I see,” I muttered, recalling the triage nurses’ note, and went in search of a stool for my interview. © 2018 Scientific American

Keyword: Schizophrenia
Link ID: 24765 - Posted: 03.19.2018

By RONI CARYN RABIN It was going to be a study that could change the American diet, a huge clinical trial that might well deliver all the medical evidence needed to recommend a daily alcoholic drink as part of a healthy lifestyle. That was how two prominent scientists and a senior federal health official pitched the project during a presentation at the luxurious Breakers Hotel in Palm Beach, Fla., in 2014. And the audience members who were being asked to help pay for the $100 million study seemed receptive: They were all liquor company executives. The 10-year government trial is now underway, and Anheuser Busch InBev, Heineken and other alcohol companies are picking up most of the tab, through donations to a private foundation that raises money for the National Institutes of Health. The N.I.H., a federal agency, is considered one of the world’s foremost medical research centers, investing over $30 billion of taxpayer money in biomedical research each year. The vast majority of the funding goes to scientists outside the N.I.H., which manages the grants and provides oversight. The alcohol study is overseen by the National Institute on Alcohol Abuse and Alcoholism, one of 27 centers under the N.I.H. The lead investigator and N.I.H. officials have said repeatedly that they never discussed the planning of the study with the industry. But a different picture emerges from emails and travel vouchers obtained by The New York Times under the Freedom of Information Act, as well as from interviews with former federal officials. The documents and interviews show that the institute waged a vigorous campaign to court the alcohol industry, paying for scientists to travel to meetings with executives, where they gave talks strongly suggesting that the study’s results would endorse moderate drinking as healthy. © 2018 The New York Times Company

Keyword: Drug Abuse
Link ID: 24764 - Posted: 03.19.2018